The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
Sun Pharma ANZ Pty Ltd
Regulatory activities for this sponsor.
Loading...
Sponsor content
615 result(s) found, displaying 31 to 40
-
Australian Public Assessment Report (AusPAR)Yonsa Mpred (abiraterone acetate + methylprednisolone) has been approved for the treatment of metastatic castration resistant prostate cancer and metastatic hormone sensitive prostate cancer.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for WINLEVI clascoterone 1% w/w cream tube.
-
Cancellation by sponsorRequested by Sun Pharma ANZ Pty Ltd
-
Cancellation by sponsorRequested by Sun Pharma ANZ Pty Ltd
-
Cancellation by sponsorRequested by Sun Pharma ANZ Pty Ltd
-
Cancellation by sponsorRequested by Sun Pharma ANZ Pty Ltd
-
Cancellation by sponsorRequested by Sun Pharma ANZ Pty Ltd
-
Cancellation by sponsorRequested by Sun Pharma ANZ Pty Ltd
-
Cancellation by sponsorRequested by Sun Pharma ANZ Pty Ltd
-
Cancellation by sponsorRequested by Sun Pharma ANZ Pty Ltd